Blog

Nataliya Kovalchuk: Treating the first BgRT SCINTIX patient in the world with RefleXion X1 at Stanford Radiation Oncology.

Photo from Nataliya Kovalchuk / LinkedIn

Aug 21, 2023, 17:00

Nataliya Kovalchuk: Treating the first BgRT SCINTIX patient in the world with RefleXion X1 at Stanford Radiation Oncology.

Quoting Nataliya Kovalchuk, Clinical Associate Professor at Stanford School of Medicine/Stanford Hospital, on LinkedIn:

”Treating the first BgRT SCINTIX patient in the world with RefleXion X1 at Stanford Radiation Oncology. Many thanks to RefleXion Medical for all the support!

SCINTIX uses the PET signal to track and treat the tumor directly without the need for motion surrogate. It also opens the door to the new exciting possibilities of using tumor-specific PET agents and treating multiple oligomets throughout the body in a single session. Viva SCINTIX!”

Source: Nataliya Kovalchuk / LinkedIn

Angela Da Silva Bill Loo Bin Han cancer Chris Brown Daniel Pham Jill Matsuoka John Valenton Lucas Vitzthum Matthew Thielman multiple oligomets Murat Surucu Nataliya Kovalchuk OncoDaily Oncology Paul Palomares Robert Conger Stanford Radiation Oncology

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage